ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001

NCI Lists ARRA Funding By Organ Site

September 18, 2009

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011